COMP <GO>
CBLL vs CNMD // FORWARD P/E MULTIPLE
CeriBell Inc. (NASDAQ) VS. CONMED Corporation (NYSE) • 15-METRIC TALLY: CBLL 4
— CNMD 7
■ METRIC PARITY
LAST: $27.82 (+2.20%) • MKT CAP: $1.07B
forward-pe
—
LAST: $45.72 (-0.09%) • MKT CAP: $1.36B
forward-pe
26.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBLL VS. CNMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBLL | CNMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 87.90% | 54.60% | +33.30 | CBLL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 7.80% | -42.80 | CNMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 11.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.89% | 11.07% | -14.96 | CNMD | /fcf-yield <GO> |
| Operating Margin | -60.00% | 7.50% | -67.50 | CNMD | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 3.40% | -63.40 | CNMD | /net-margins <GO> |
| Revenue Growth (YoY) | 36.10% | 5.20% | +30.90 | CBLL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.82% | -1.82 | CNMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 14.75 | 1.91 | +12.84 | CBLL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | CNMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.0 | 40.6 | +13.44 | CBLL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 26.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.07B | $1.36B | -$294.9M | CNMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBLL REV | CNMD REV | CBLL GROSS % | CNMD GROSS % | CBLL FCF | CNMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $89.1M | $1.37B | 87.9% | 54.6% | -$41.6M | $150.9M |
| FY 2024 | $65.4M | $1.31B | 86.7% | 56.1% | -$36.4M | $153.9M |
| FY 2023 | $45.2M | $1.24B | — | — | -$29.2M | $125.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBLL // BETA —
CNMD // BETA —